Short answer: there isn’t a public, fixed “production cost” for acyclovir. The cost to produce it (API or finished dosage form) is highly variable and depends on scale, purity requirements, location, suppliers, and regulatory overhead. It’s also typically considered commercially sensitive information.
What drives the cost (high-level)
- Raw materials and solvents: price and availability of the starting materials and any specialized reagents.
- Process efficiency: overall yield per kilogram of API and the amount of purification required.
- GMP and quality control: compliance, analytical testing, stability studies, batch release testing.
- Labor and utilities: manufacturing labor, energy, water, and waste handling.
- Capital and overhead: depreciation of equipment, facility costs, maintenance, and environmental controls.
- Formulation and packaging (if finished dosage form): excipients, filling, blistering/blister pack, labeling, stability packaging.
- Regulatory and quality systems: validation activities, audits, and documentation.
- Logistics and regulatory fees: site approvals, import/export controls, and distribution.
If you’re evaluating a project or seeking numbers, the typical approach is to get quotes from contract manufacturing organizations (CMOs) for the API and/or the finished product. I can help you with:
- A cost-model template to estimate total cost per kg of API and per unit of product.
- A request-for-quote (RFQ) checklist to send to CMOs.
- A breakdown you can use to compare suppliers.
Would you like me to draft a simple cost-model template or an RFQ checklist? If you can share:
- whether you want API cost or finished dosage form cost
- target annual volume (kg API or number of units)
- target purity/specifications
- region or preferred CMOs
…I can tailor the guidance.